BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5383630)

  • 1. [Favorable action of levo-asparaginase on the growth of Ehrlich's ascitic carcinoma (in normal animals and animals previously "vaccinated" against the same ascitic tumor)].
    Nicolin A; Napoli PA
    Arch Ital Patol Clin Tumori; 1969; 12(3):177-87. PubMed ID: 5383630
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of ascitic fluid globulins on the growth of leukemia P388/DOX and Ehrlich's carcinoma in mice].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Nov; 114(11):518-9. PubMed ID: 1290828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tween 80 and immunological defense against Ehrlich's ascitic carcinoma].
    Castagnone Prati D; Di Roberto F; Ingrami A
    Arch Ital Patol Clin Tumori; 1967; 10(1):29-35. PubMed ID: 5600139
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of anticancer efficacy of aonitine-containing agent BC1 against ascite and solid forms of Ehrlich's carcinoma.
    Dasyukevich OI; Solyanik GI
    Exp Oncol; 2007 Dec; 29(4):317-9. PubMed ID: 18199991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On a new antibiotic of streptomycetic origin active against Ehrlich's ascitic carcinoma].
    Bertelli A; Bonmassar E; Montagnani-Marelli A; Zannini E
    Arch Ital Patol Clin Tumori; 1967; 10(1):21-8. PubMed ID: 5600138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of mouse interferons on the development of Ehrlich ascitic carcinoma].
    Solov'ev VD; Krispin TI; Balandin IG
    Biull Eksp Biol Med; 1980 Mar; 89(3):330-2. PubMed ID: 6155950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronobiological analysis of thyroxine action on cell proliferation in the hypotetraploid strain of Ehrlich's ascitic tumor].
    Romanov IuA; Stepanenko VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):610-2. PubMed ID: 2633828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of embryonic thymus and liver cells on the development of the ascitic form of Ehrlich's carcinoma].
    Lebedev KA; Petrakova KV; Selivakhina VA
    Ontogenez; 1978; 9(6):632-5. PubMed ID: 569266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cysteamine content in mice tissues and in cells of Ehrlich's ascitic carcinoma at the period of its maximal radioprotective action].
    Tarasenko AG; Lieh Suan T'u ; Gusareva EV; Graevskiĭ EIa
    Dokl Akad Nauk SSSR; 1968; 178(4):951-4. PubMed ID: 5660467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of an anabolic hormone (dimethazine) on the immunological state of the mouse toward Ehrlich's ascitic carcinoma].
    Bonmassar E; Melan F; Montagnani-Marelli A
    Arch Ital Patol Clin Tumori; 1967; 10(1):37-40. PubMed ID: 5600140
    [No Abstract]   [Full Text] [Related]  

  • 12. [14C-riboflavin metabolism in mice with Ehrlich's ascitic tumor].
    Trebukhina RV; Mikhal'tsevich GN
    Vopr Pitan; 1978; (4):49-55. PubMed ID: 685222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive action of L-asparaginase in mice.
    Nelson SD; Lee MB; Bridges JM
    Br J Haematol; 1969 Dec; 17(6):610. PubMed ID: 4901993
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of x-rays on destructive processes in Ehrlich's ascitic tumor].
    Ezdanian BA; Manvelian KR
    Zh Eksp Klin Med; 1971; 11(4):19-25. PubMed ID: 5170665
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of homogenates of different tissues on the radiation-protective action of cystamine in the process of irradiation of cells of Ehrlich's ascitic carcinoma in vitro].
    Nekrasova IV
    Dokl Akad Nauk SSSR; 1965 Jun; 162(4):950-1. PubMed ID: 5872734
    [No Abstract]   [Full Text] [Related]  

  • 16. [On immunosuppression with levo-asparaginase in experimental renal allotransplantation. Preliminary note].
    Rocchi V; Libra S; Gruttadauria G; Bordi A; Ricotta M
    Chir Patol Sper; 1970 Aug; 18(4):207-14. PubMed ID: 4945263
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the presence of substances with anti-complement activity in the blood and ascitic fluid in Ehrlich's tumor in mice].
    Carretti N
    Boll Soc Ital Biol Sper; 1969 Apr; 45(8):470-4. PubMed ID: 5369737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of thymus lipid extract B on carbohydrate metabolism in mice with implants of Ehrlich's ascitic carcinoma].
    Juvină E; Mreană G
    Stud Cercet Endocrinol; 1970; 21(6):503-7. PubMed ID: 4324273
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Ehrlich's ascitic tumour cells in preparing hyperimmune fluid against third component (C3) of human serum complement.
    Gupta AK; Rao KM; Manja KS
    Indian J Exp Biol; 1980 May; 18(5):532-3. PubMed ID: 6776040
    [No Abstract]   [Full Text] [Related]  

  • 20. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.